EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Hepatitis Delta Virus Testing and Prevalence Among Chronic Hepatitis B Patients Across Three U.S. Safety-net Health Systems

Robert J Wong, Mamta K Jain, Bolin Niu, Yi Zhang, George Therapondos, Mae Thamer

Clinical Gastroenterology and Hepatology · 2025-10 · 23 (11) · 1954-1963

DOI: 10.1016/j.cgh.2024.09.025 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025-10. Verfasst von Robert J Wong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California; Gastroenterology Section Veterans Affairs…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis D, Hepatitis Delta Virus, Safety-net Providers. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Gilead Sciences Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Despite a high prevalence of risk factors associated with hepatitis delta virus (HDV) infection among safety-net populations, data evaluating HDV testing and prevalence are limited. We aim to evaluate HDV testing practices and HDV prevalence among an ethnically diverse, multi-center cohort of safety-net patients with chronic hepatitis B (CHB). METHODS: We retrospectively evaluated 13,218 patients with CHB (54.2% male, 57.9% non-White minorities, 12.5% human immunodeficiency virus, and 23.0% hepatitis C virus) across 3 United States safety-net health systems from 2010 to 2022 to evaluate proportion tested for HDV and proportion positive among those tested. Adjusted multivariate logistic regression models evaluated for predictors of HDV testing and predictors of anti-HDV positive. RESULTS: Anti-HDV testing was performed in 6.1% overall and in 4.9% that met American Association for the Study of Liver Diseases criteria for HDV testing. Greater odds of testing were observed in men vs women (odds ratio [OR], 1.49; 95% confidence interval [CI], 1.27-1.75), Asian individuals vs White individuals (OR, 2.18; 95% CI, 1.74-2.72), Black/African American individuals vs White individuals (OR, 1.29; 95% CI, 1.07-1.56), and patients with Medicare or Medicaid. Among patients with CHB tested for HDV, 15.7% were positive (22.9% among those meeting American Association for the Study of Liver Diseases HDV testing criteria). Only 2 patients (1.6%) had follow-up HDV RNA testing. Greater proportion of anti-HDV positive was observed in patients with baseline cirrhosis (47.4% vs 13.3%; P < .001), and patients with Medicare or Medicaid vs those with commercial insurance. CONCLUSIONS: Among an ethnically diverse, multi-center safety-net cohort of patients with CHB, low rates of HDV testing were observed, even among those with high-risk HDV risk factors. Among those tested, 15.7% were positive, only 2 had follow up RNA testing. This highlights the need for greater awareness, education, and advocacy to improve HDV testing rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHepatitis DHepatitis Delta VirusSafety-net ProvidersAdultAgedFemaleHumansMaleMiddle AgedYoung AdultPrevalenceRetrospective StudiesRisk FactorsUnited States

Stichwörter der Autor:innen

Hepatitis BHepatitis DPrevalenceSafety-netTesting

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California; Gastroenterology Section Veterans Affairs Palo Alto Healthcare System, Palo Alto, California. Electronic addres…
  • Division of Infectious Diseases and Geographic Medicine, UT Southwestern Medical Center and Parkland Health, Dallas, Texas.
  • Division of Gastroenterology and Hepatology, MetroHealth, Cleveland, Ohio.
  • Medical Technology and Practice Patterns Institute, Bethesda, Maryland.
  • Multi-Organ Transplant Institute, Ochsner Health System, New Orleans, Louisiana.

Förderung

  • Gilead Sciences Inc

Zitieren

APA

Wong, R. J., Jain, M. K., Niu, B., Zhang, Y., Therapondos, G., & Thamer, M. (2025). Hepatitis Delta Virus Testing and Prevalence Among Chronic Hepatitis B Patients Across Three U.S. Safety-net Health Systems. Clinical Gastroenterology and Hepatology, 23(11), 1954-1963. https://doi.org/10.1016/j.cgh.2024.09.025

Vancouver

Wong RJ, Jain MK, Niu B, Zhang Y, Therapondos G, Thamer M. Hepatitis Delta Virus Testing and Prevalence Among Chronic Hepatitis B Patients Across Three U.S. Safety-net Health Systems. Clinical Gastroenterology and Hepatology. 2025;23(11):1954-1963. doi:10.1016/j.cgh.2024.09.025

BibTeX
@article{Wong2025,
  author = {Wong, Robert J and Jain, Mamta K and Niu, Bolin and Zhang, Yi and Therapondos, George and Thamer, Mae},
  title = {Hepatitis Delta Virus Testing and Prevalence Among Chronic Hepatitis B Patients Across Three U.S. Safety-net Health Systems},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2025},
  volume = {23},
  number = {11},
  pages = {1954--1963},
  doi = {10.1016/j.cgh.2024.09.025}
}
Kostenlos starten →